Full-Time

Global Head of Process Engineering

Confirmed live in the last 24 hours

Sanofi

Sanofi

10,001+ employees

Develops pharmaceuticals and life-saving vaccines

Biotechnology
Healthcare

Senior, Expert

Cambridge, MA, USA

Onsite presence required.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • Ph.D. in Chemical Engineering, Pharmaceutical Sciences, or equivalent with 10+ years in pharma/biotech.
  • Strong track record with peer-reviewed publications, patents, and scientific conference presentations; extensive network in academia and industry.
  • Proven ability to create vision, develop strategy, align resources, manage execution, and adapt to achieve goals.
  • Expertise in pre-clinical, clinical, and commercial phases, including process design, characterization, validation, and regulatory filings.
  • Deep understanding of CMC aspects of GMP development for both drug substance and drug product, with strong knowledge of quality, regulatory affairs, and manufacturing and supply.
  • Proven ability to deliver effective engineering solutions for drug substances and products, with a strong grasp of solid-state characterization and control (as it relates to drug substances used in solid oral dosage formulations), and a creative approach to enhancing technical capabilities.
  • Demonstrated ability to deliver engineering solutions, manage projects, and lead diverse teams in a matrix organization.
  • Proven leadership in managing CDMOs, leading GMP activities, and fostering a culture of experimentation, thoughtful risk-taking, and continual learning.
Responsibilities
  • Reporting to the Global Head of Synthetics CMC Development, you will be a member of the Synthetics Leadership Team, responsible for devising the science, innovation, and CMC strategy for all synthetic/small molecule drug candidates.
  • You will lead a global organization (~50 FTEs in France/USA) responsible for applying cutting-edge process engineering principles across both drug substance (DS) & drug product (DP) design.
  • You will drive the development of innovative, efficient, environmentally friendly, cost-effective, and phase-appropriate DS/DP manufacturing processes for Sanofi’s small molecule R&D pipeline.
  • You will be responsible for supporting clinical/commercial process development, risk assessments, QbD (Quality by Design) control strategy, tech transfer, scale-up and process performance qualification/validation.
  • You will develop and deploy advanced technologies for automated experimentation, robotics, lab informatics, predictive modeling, crystallization, integration of process analytical technologies, kinetic/mechanistic analysis of synthetic transformations.
  • You will drive the application of artificial intelligence & machine learning tools for process simulation and optimization.
  • You will establish technology platforms for activities such as DS/DP continuous manufacturing, process safety/thermal hazards evaluation, unit operation modeling, development of digital twins, crystallization, solubility enhancement, rapid formulation development, and process characterization.

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical conditions. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi's products include prescription medicines, over-the-counter items, and vaccines, which are distributed to patients, healthcare professionals, and governments. What sets Sanofi apart from its competitors is its strong emphasis on scientific innovation and strategic partnerships, allowing it to maintain a diverse product pipeline and a global presence. The company's goal is to enhance health outcomes and improve the quality of life for individuals worldwide.

Company Stage

Grant

Total Funding

$2B

Headquarters

Paris, France

Founded

N/A

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Sanofi's strong financial performance, as evidenced by its raised 2024 outlook, indicates robust growth and stability.
  • The company's strategic investments in innovative biotech firms, such as Ventyx Biosciences, enhance its pipeline and potential for breakthrough therapies.
  • Sanofi's Dupixent receiving a positive recommendation for expanded use in children demonstrates its leadership in addressing unmet medical needs.

What critics are saying

  • The highly competitive pharmaceutical market requires Sanofi to continuously innovate to maintain its market position.
  • Regulatory challenges in different regions could delay product approvals and impact revenue streams.

What makes Sanofi unique

  • Sanofi's extensive R&D efforts and strategic partnerships, such as with Orano Med for radioligand therapies, set it apart in the competitive pharmaceutical landscape.
  • The company's global reach and focus on patient-centric solutions allow it to effectively navigate diverse regulatory environments and deliver innovative treatments worldwide.
  • Sanofi's investment in sustainable initiatives, like SureChill's 'Cooling as a Service' model, highlights its commitment to addressing healthcare challenges in emerging markets.

Help us improve and share your feedback! Did you find this helpful?